technetium tc 99m pentetate has been researched along with losartan potassium in 2 studies
Studies (technetium tc 99m pentetate) | Trials (technetium tc 99m pentetate) | Recent Studies (post-2010) (technetium tc 99m pentetate) | Studies (losartan potassium) | Trials (losartan potassium) | Recent Studies (post-2010) (losartan potassium) |
---|---|---|---|---|---|
3,336 | 275 | 394 | 24,390 | 2,493 | 5,408 |
Protein | Taxonomy | technetium tc 99m pentetate (IC50) | losartan potassium (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 8.53 | |
Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0082 | |
Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0049 | |
Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0082 | |
5-hydroxytryptamine receptor 1A | Mus musculus (house mouse) | 0.0082 | |
Type-1 angiotensin II receptor | Cavia porcellus (domestic guinea pig) | 0.018 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bitonti, AJ; Clark, D; Dumont, JA; Evans, S; Newman, SP; Pickford, M | 1 |
Adachi, Y; Nakagawa, Y; Nishio, A | 1 |
1 trial(s) available for technetium tc 99m pentetate and losartan potassium
Article | Year |
---|---|
Delivery of an erythropoietin-Fc fusion protein by inhalation in humans through an immunoglobulin transport pathway.
Topics: Administration, Inhalation; Adolescent; Adult; Aerosols; Dose-Response Relationship, Drug; Drug Delivery Systems; Erythropoietin; Histocompatibility Antigens Class I; Humans; Lung; Male; Middle Aged; Nebulizers and Vaporizers; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Fc; Recombinant Fusion Proteins; Reticulocytes; Technetium Tc 99m Pentetate; Vital Capacity | 2005 |
1 other study(ies) available for technetium tc 99m pentetate and losartan potassium
Article | Year |
---|---|
In patients treated with peritoneal dialysis, icodextrin improves erythropoietin-resistant anemia through blockade of asialo receptors on hepatocytes.
Topics: Alkaline Phosphatase; Anemia; Asialoglycoprotein Receptor; Drug Resistance; Erythropoietin; Glucans; Glucose; Hematocrit; Hemodialysis Solutions; Humans; Icodextrin; Kidney Failure, Chronic; Peritoneal Dialysis; Radiopharmaceuticals; Recombinant Proteins; Technetium Tc 99m Aggregated Albumin; Technetium Tc 99m Pentetate | 2006 |